Mural Oncology PLC (MURA)
3.835
+0.06
(+1.46%)
USD |
NASDAQ |
May 07, 16:00
3.835
0.00 (0.00%)
After-Hours: 16:02
Mural Oncology Total Return Level: 3.78 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 3.78 |
May 03, 2024 | 3.83 |
May 02, 2024 | 3.82 |
May 01, 2024 | 3.78 |
April 30, 2024 | 3.70 |
April 29, 2024 | 3.70 |
April 26, 2024 | 3.58 |
April 25, 2024 | 3.53 |
April 24, 2024 | 3.60 |
April 23, 2024 | 3.66 |
April 22, 2024 | 3.59 |
April 19, 2024 | 3.57 |
April 18, 2024 | 3.57 |
April 17, 2024 | 3.76 |
April 16, 2024 | 3.91 |
April 15, 2024 | 4.09 |
April 12, 2024 | 4.22 |
April 11, 2024 | 4.30 |
April 10, 2024 | 4.12 |
April 09, 2024 | 4.17 |
April 08, 2024 | 4.21 |
April 05, 2024 | 4.33 |
April 04, 2024 | 4.60 |
April 03, 2024 | 4.53 |
April 02, 2024 | 4.73 |
Date | Value |
---|---|
April 01, 2024 | 4.85 |
March 28, 2024 | 4.89 |
March 27, 2024 | 4.95 |
March 26, 2024 | 4.49 |
March 25, 2024 | 4.32 |
March 22, 2024 | 4.51 |
March 21, 2024 | 4.37 |
March 20, 2024 | 4.40 |
March 19, 2024 | 4.52 |
March 18, 2024 | 4.75 |
March 15, 2024 | 4.81 |
March 14, 2024 | 4.82 |
March 13, 2024 | 5.18 |
March 12, 2024 | 5.19 |
March 11, 2024 | 5.29 |
March 08, 2024 | 5.40 |
March 07, 2024 | 5.46 |
March 06, 2024 | 5.37 |
March 05, 2024 | 5.35 |
March 04, 2024 | 5.41 |
March 01, 2024 | 5.39 |
February 29, 2024 | 5.29 |
February 28, 2024 | 5.36 |
February 27, 2024 | 5.21 |
February 26, 2024 | 5.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.29
Minimum
Dec 18 2023
6.01
Maximum
Dec 28 2023
4.447
Average
4.43
Median
Dec 22 2023
Total Return Level Benchmarks
Amarin Corp PLC | 0.98 |
Jazz Pharmaceuticals PLC | 109.85 |
Prothena Corp PLC | 23.75 |
Iterum Therapeutics PLC | 1.59 |
GH Research PLC | 11.70 |